P

Inventor

SAUERBERG PER

DK101 patents
⚠️ This page may combine multiple inventors who share the name “SAUERBERG PER”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

NOVO NORDISK AS

34 patents
US5043345AAug 27, 1991

Piperidine compounds and their preparation and use

NOVO NORDISK AS111 citations97
US5041455AAug 20, 1991

Piperidine compounds and their preparation and use

NOVO NORDISK AS101 citations97
US5260314ANov 9, 1993

Certain 3-(1,2,5-oxa- or thiadiazol-4-yl)-1-azabicyclo [2.2.2]octanes having pharmaceutical properties

NOVO NORDISK AS59 citations96
US10278923B2May 7, 2019

Oral dosing of GLP-1 compounds

NOVO NORDISK AS29 citations93
US10086047B2Oct 2, 2018

Solid compositions comprising a GLP-1 agonist and a salt of N-(8-(2-hydroxybenzoyl)amino)caprylic acid

NOVO NORDISK AS26 citations93
US6602901B2Aug 5, 2003

Compounds useful in the treatment of conditions mediated by peroxisome proliferator-activated receptors (PPAR)

NOVO NORDISK AS14 citations93
US6468996B1Oct 22, 2002

Substituted hetero-polycyclic compounds as PPARα and PPARγ activators

NOVO NORDISK AS33 citations93
US6248781B1Jun 19, 2001

Compounds useful in the treatment of conditions mediated by peroxisome proliferator-activated receptors (PPAR)

NOVO NORDISK AS26 citations93
US5328923AJul 12, 1994

Heterocyclic compounds and use

NOVO NORDISK AS27 citations93
US5328924AJul 12, 1994

Heterocyclic compounds and their use

NOVO NORDISK AS30 citations93
US11382957B2Jul 12, 2022

Solid compositions comprising a GLP-1 agonist and a salt of N-(8-(2-hydroxybenzoyl)amino)caprylic acid

NOVO NORDISK AS11 citations92
US10960052B2Mar 30, 2021

Solid compositions comprising a GLP-1 agonist and a salt of N-(8-(2-hydroxybenzoyl) amino) caprylic acid

NOVO NORDISK AS19 citations92
US7202213B2Apr 10, 2007

Combination therapy using a dual PPAR-α/PPAR-γ activator and a GLP-1 derivative for the treatment of metabolic syndrome and related diseases and disorders

NOVO NORDISK AS21 citations92
US7091245B2Aug 15, 2006

Compounds, their preparation and use

NOVO NORDISK AS22 citations92
US7067530B2Jun 27, 2006

Compounds, their preparation and use

NOVO NORDISK AS22 citations92
US6869967B2Mar 22, 2005

Peroxisome proliferator-activated receptor (PPAR) active vinyl carboxylic acid derivatives

NOVO NORDISK AS26 citations92
US6569901B2May 27, 2003

Alkynyl-substituted propionic acid derivatives, their preparation and use

NOVO NORDISK AS33 citations92
US6555577B1Apr 29, 2003

Compounds, their preparation and use

NOVO NORDISK AS28 citations92
US6274608B1Aug 14, 2001

Compounds, their preparation and use

NOVO NORDISK AS23 citations92
US9993430B2Jun 12, 2018

Tablet formulation comprising semaglutide and a delivery agent

NOVO NORDISK AS18 citations90
US5262427ANov 16, 1993

3-substituted and optionally 1-substituted azacyclic or azabicyclic compounds, pharmaceutical compositions, thereof and their use as stimulants of cognitive functions

NOVO NORDISK AS21 citations89
US7220877B2May 22, 2007

Compounds, their preparation and use

NOVO NORDISK AS12 citations84
US7129268B2Oct 31, 2006

Peroxisome proliferator activated receptor-active arylene acetic acid derivatives

NOVO NORDISK AS20 citations84
US6972294B1Dec 6, 2005

Compounds, their preparation and use

NOVO NORDISK AS18 citations84
US6867218B2Mar 15, 2005

Compounds, their preparation and use

NOVO NORDISK AS17 citations84
US6214820B1Apr 10, 2001

Compounds, their preparation and use

NOVO NORDISK AS15 citations84
US9498534B2Nov 22, 2016

Derivatives of GLP-1 like peptides, and uses thereof

NOVO NORDISK AS13 citations83
US5578602ANov 26, 1996

Certain 1-azabicyclo[3.3.1]nonene derivatives and their pharmacological uses

NOVO NORDISK AS17 citations82
US5571826ANov 5, 1996

Heterocyclic compounds and their preparation and use

NOVO NORDISK AS14 citations82
US5527813AJun 18, 1996

Heterocyclic compounds and their preparation and use

NOVO NORDISK AS17 citations82
US11033499B2Jun 15, 2021

Tablet formulation comprising a GLP-1 peptide and a delivery agent

NOVO NORDISK AS8 citations80
US5356912AOct 18, 1994

3-(5-isoxazolyl)-1-methyl-1,2,3,6-tetrahydropyridine useful for treating Alzheimer's disease

NOVO NORDISK AS17 citations79
US12239739B2Mar 4, 2025

Oral dosing of GLP-1 compounds

NOVO NORDISK AS2 citations74
US6353018B1Mar 5, 2002

Compounds, their preparation and use

NOVO NORDISK AS9 citations74

HIGH POINT PHARMACEUTICALS LLC

5 patents

VTV THERAPEUTICS LLC

4 patents

FERROSAN AS

2 patents

SAUERBERG PER

1 patent

GARIBAY PATRICK WILLIAM

1 patent

NOVO NORDISK ALS

1 patent

MADSEN ALICE RAVN

1 patent

LILLY CO ELI

1 patent

Showing the top 50 of 101 patents by PatentIndex Score.